Cadeler A/S (CDLR)

Ligand Pharmaceuticals Revenue

Cadeler had revenue of 65.47M EUR in the quarter ending March 31, 2025, with 243.46% growth. This brings the company's revenue in the last twelve months to 295.15M, up 171.33% year-over-year. In the year 2024, Cadeler had annual revenue of 248.74M with 128.99% growth.

• Revenue (ttm): 295.15M EUR
• Revenue Growth: +171.33%
• P/S Ratio: 5.63
• Revenue / Employee: 447,874 EUR
• Employees: 659
• Market Cap: 1.80B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	248.74M	140.12M	128.99%
Dec 31, 2023	108.62M	2.20M	2.07%
Dec 31, 2022	106.42M	45.49M	74.64%
Dec 31, 2021	60.94M	41.44M	212.49%
Dec 31, 2020	19.50M	-18.88M	-49.19%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.